Story thread · 7 reports / 7 sources

New pancreatic cancer drug gives South Portland man hope for longer life

pressherald.com · 12dShare

Eugene Slobodzian of South Portland is taking the new drug approved by the FDA for treating pancreatic cancer. (Gregory Rec/Staff Photographer) " data-image-caption=" Eugene Slobodzian, of South Portland, was part of an expanded access trial of daraxonrasib, a new drug to treat pancreatic cancer that got FDA approval last week. In clinical trials, the drug doubled patients’ life expectancy, from a median of 6.7 months with chemotherapy to 13.2 months. (Gregory Rec/Staff Photographer) " data-large-file="https://www.pressherald.com/wp-content/uploads/sites/4/2026/09/43777018_20260902_cancer-drug_1.jpg?w=780" /> Eugene Slobodzian has been taking daraxonrasib since July as part of an expanded access trial. Last week, the FDA approved it for wide use, potentially doubling patients' life expectancy to 13 months.

First report: A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs — nytimes.com, 15d